{"transactions":[{"id":922355,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":67998,"kind":"person","name":"Connolly Joan","position":1,"cik":"0002041481","reported_name":"Connolly Joan","relationship":{"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T16:07:21.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in substantially equal amounts for 48 months, subject to the reporting person's continued service."}],"balance_after":195000,"derivative":{"exercise_price":9.53,"expiration_date":"2036-01-30","underlying":"Common Shares","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0000929638-26-000479","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2041481/000092963826000479/form4.xml","form_type":"4"}},{"id":1383087,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":67998,"kind":"person","name":"Connolly Joan","position":1,"cik":"0002041481","reported_name":"Connolly Joan","relationship":{"officer":true,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-22T16:07:13.000Z","date":"2024-10-21","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Non-qualified stock option grant awarded pursuant to the Employment Agreement dated October 21, 2024 between Ms. Connolly and enGene USA, Inc. as an inducement award outside of the Amended and Restated enGene Holdings Inc. 2023 Incentive Equity Plan in accordance with NASDAQ Listing Rule 5635(c)(4).  This option vests at 25% on October 21, 2025, which is the first anniversary of the employment commencement date, with the remaining portion to vest monthly over the remaining three years, subject to Ms. Connolly's continued service."}],"balance_after":210000,"derivative":{"exercise_price":9.83,"expiration_date":"2034-10-21","underlying":"Common Shares","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0000929638-24-003557","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2041481/000092963824003557/form4.xml","form_type":"4"}}]}